In addition to improved glycaemic control, GLP-1 also effectively reduces lipid load and free fatty acid (FFA)-induced liver steatosis (Gupta et al., 2010; Wajcberg and Amarah, 2010; Cuthbertson et al., 2012). Here, GCG is linked to fatty liver disease.